KaloBios Names Controversial Martin Shkreli As Its New CEO
November 20, 2015 at 08:45 AM EST
Shares of KaloBios Pharmaceuticals Inc (NASDAQ: KBIO) rose more than 400 percent on Thursday after the company announced Martin ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.